Sensex
84,065.75 profit arw 485.35 (0.58%)
Nifty
25,867.30 profit arw 173.60 (0.68%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
Equity

As on : 09-Feb-2026
Corporate News
09-Feb-2026     19:31

Aurobindo Pharma board considers merger of subsidiaries

The board of Aurobindo Pharma at its meeting held on 09 February 2026 has approved a proposal to file a scheme of amalgamation for merger of Auro Vaccines, a wholly owned step-down subsidiary of the Company with Curateq Biologics, a wholly owned subsidiary of the Company, with Hon'ble NCLT, Hyderabad.

Powered by Capital Market - Live News

INDIAN INDICES

Sensex

84,065.75 485.35 (0.58%)

Nifty

25,867.30 173.60 (0.68%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

27,027.17 467.21(1.76%)